Filing Details
- Accession Number:
- 0001437749-24-036551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 16:18:08
- Reporting Period:
- 2024-11-29
- Accepted Time:
- 2024-12-03 16:18:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069530 | Cassava Sciences Inc | SAVA | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1839551 | William James Kupiec | 6801 N Capital Of Texas Hwy, Bldg 1 Suite 300 Austin TX 78731 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-29 | 4,000 | $3.87 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
